Winston-Salem, NC, United States of America

Steven M Toler

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steven M Toler

Introduction

Steven M Toler is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of medical treatments, particularly in addressing bladder disorders and hypertension. With a total of 2 patents, Toler's work reflects a commitment to advancing healthcare solutions.

Latest Patents

Toler's latest patents include a method of treating bladder disorders, which involves the use of dexmecamylamine, substantially free of exo-R-mecamylamine. This innovative approach aims to provide relief for individuals suffering from overactive bladder. Additionally, he has developed a combination therapy for managing hypertension, which includes mecamylamine along with an ACE inhibitor, an AT2 receptor inhibitor, or a renin inhibitor.

Career Highlights

Toler is associated with Targacept, Inc., where he has been instrumental in developing new therapeutic strategies. His work has contributed to the understanding and treatment of complex medical conditions, showcasing his expertise in pharmacology and therapeutic innovation.

Collaborations

Throughout his career, Toler has collaborated with esteemed colleagues such as Merouane Bencherif and David A Hosford. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.

Conclusion

Steven M Toler's contributions to medical innovation, particularly in the treatment of bladder disorders and hypertension, highlight his role as a significant inventor in the healthcare field. His patents reflect a dedication to improving patient outcomes through innovative therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…